Robert M. Mader
Impact in
- Chemical Health and Safety top 1%
- Occupational Therapy top 0.5%
- Safe Handling of Antineoplastic Drugs
Papers in
- Oncology 79
- Cancer Treatment and Pharmacology 36
- Colorectal Cancer Treatments and Studies 23
- HER2/EGFR in Cancer Research 13
- Co-authors
- Blanka Rizovski (22 shared papers)Maria Fuerhacker (6 shared papers)Guenther G. Steger (34 shared papers)Günther Steger (22 shared papers)Rupert Bartsch (34 shared papers)Ursula Pluschnig (29 shared papers)Susanne N. Mahnik (5 shared papers)Christoph Zielinski (32 shared papers)
- Journals
- Journal of Clinical Oncology (9 papers)Cancer Chemotherapy and Pharmacology (6 papers)Breast Cancer Research and Treatment (5 papers)British Journal of Cancer (5 papers)European Journal of Cancer (4 papers)
- Partner nations
- AustriaGermanyUnited States
In The Last Decade
Robert M. Mader
176 papers receiving 4.1k citations
Robert M. Mader's Hit Papers
Peers
Comparison fields: 5 of 151
- Chemical Health and Safety 42
- Occupational Therapy 228
- Oncology 1.2k
- Cancer Research 612
- Pollution 372
Countries citing papers authored by Robert M. Mader
This map shows the geographic impact of Robert M. Mader's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert M. Mader with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert M. Mader more than expected).
Fields of papers citing papers by Robert M. Mader
This network shows the impact of papers produced by Robert M. Mader. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert M. Mader. The network helps show where Robert M. Mader may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert M. Mader, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 186 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 218 | |
| 2 | 2005 | 133 | |
| 3 | 2007 | 115 | |
| 4 | 2007 | 115 | |
| 5 | 2007 | 111 | |
| 6 | Safety and immunogenicity of a single-shot live-attenuated chikungunya vaccine: a double-blind, multicentre, randomised, placebo-controlled, phase 3 trial Hit paper breakdown → | 2023 | 110 |
| 7 | 2004 | 102 | |
| 8 | 2005 | 92 | |
| 9 | 1998 | 90 | |
| 10 | 2003 | 88 | |
| 11 | 2007 | 84 | |
| 12 | 5-fluorouracil kinetics in the interstitial tumor space: clinical response in breast cancer patients. | 1997 | 80 |
| 13 | 1994 | 78 | |
| 14 | 2016 | 72 | |
| 15 | 2003 | 71 | |
| 16 | 2015 | 70 | |
| 17 | 2012 | 70 | |
| 18 | 2006 | 61 | |
| 19 | 2011 | 61 | |
| 20 | 2009 | 59 |
About Robert M. Mader
Robert M. Mader is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Cancer Research and Dermatology, having authored 186 papers that have together received 4.2k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (36 papers), Colorectal Cancer Treatments and Studies (23 papers), Chemotherapy-related skin toxicity (21 papers), HER2/EGFR in Cancer Research (13 papers), Safe Handling of Antineoplastic Drugs (11 papers), Cancer Genomics and Diagnostics (9 papers), Lung Cancer Treatments and Mutations (9 papers) and Genetic factors in colorectal cancer (9 papers). The work is most often cited by research in Chemical Health and Safety (42 citations), Occupational Therapy (228 citations), Oncology (1.2k citations), Cancer Research (612 citations) and Pollution (372 citations). Robert M. Mader has collaborated with scholars based in Austria, Germany and United States. Frequent co-authors include Blanka Rizovski, Maria Fuerhacker, Guenther G. Steger, Günther Steger, Rupert Bartsch, Ursula Pluschnig, Susanne N. Mahnik, Christoph Zielinski, Michael Gnant and Margaretha Rudas. Their work appears in journals such as Journal of Clinical Oncology, Cancer Chemotherapy and Pharmacology, Breast Cancer Research and Treatment, British Journal of Cancer and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.